Aerovate Therapeutics, Inc.

NasdaqGM:AVTE Stock Report

Market Cap: US$75.1m

Aerovate Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:AVTE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Jun 24BuyUS$1,549,944RA Capital Management, L.P.Company928,110US$1.67
02 May 24SellUS$41,631Marinus VerwijsIndividual1,981US$21.02
09 Apr 24SellUS$334,478Atlas Venture L.P.Company11,882US$28.15

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AVTE?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders29,7360.103%
General Public377,0421.31%
Institutions11,476,91639.7%
VC/PE Firms16,990,81958.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.4%.

Top Shareholders

Top 25 shareholders own 94.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.8%
RA Capital Management, L.P.
9,192,092US$23.9m0%0.29%
13%
Sofinnova Investment, Inc.
3,758,686US$9.8m0%0.85%
7.76%
TCG Crossover Management, LLC
2,240,809US$5.8m0%0.52%
6.23%
Atlas Venture L.P.
1,799,232US$4.7m0%0.54%
4.89%
Deerfield Management Company, L.P. Series C
1,411,608US$3.7m0%0.06%
3.99%
The Vanguard Group, Inc.
1,151,873US$3.0m4.21%no data
3.3%
BlackRock, Inc.
953,676US$2.5m-2.99%no data
2.75%
Driehaus Capital Management LLC
794,992US$2.1m0%0.01%
2.18%
Baker Bros. Advisors LP
628,939US$1.6m0%0.02%
2.08%
Affinity Asset Advisors, LLC
600,000US$1.6m200%0.27%
1.68%
Eversept Partners, L.P.
485,141US$1.3m0%0.1%
1.61%
Octagon Capital Advisors LP
465,440US$1.2m0%0.19%
1.52%
Opaleye Management Inc.
440,000US$1.1m0%0.19%
1.43%
GSA Capital Partners LLP
413,795US$1.1m227%0.08%
1.27%
Ikarian Capital, LLC
367,965US$956.7k0%0.28%
1.27%
State Street Global Advisors, Inc.
367,468US$955.4k7.7%no data
1.24%
Acadian Asset Management LLC
359,376US$934.4k0%no data
1.08%
Two Sigma Investments, LP
313,114US$814.1k12.3%no data
1.01%
Geode Capital Management, LLC
291,887US$758.9k-7.97%no data
0.9%
Bank of America Corporation, Asset Management Arm
261,031US$678.7k1,260%no data
0.81%
Citigroup Inc.,Banking and Securities Investments
233,411US$606.9k6,480%no data
0.68%
Millennium Management LLC
196,644US$511.3k-69.4%no data
0.61%
Morgan Stanley, Investment Banking and Brokerage Investments
177,562US$461.7k338%no data
0.54%
Eaton Vance Management
156,405US$406.7k1,310%no data
0.39%
ADAR1 Capital Management, LLC
113,075US$294.0k-54.2%0.05%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 02:20
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aerovate Therapeutics, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vamil DivanGuggenheim Securities, LLC
Eun Kyung YangJefferies LLC
Yuchen DingJefferies LLC